Amplifications of oncogeneerbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction
- 1 October 1996
- journal article
- other
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 40 (3), 271-281
- https://doi.org/10.1007/bf01806816
Abstract
A new method of measuring gene copy number in small samples of DNA was used to measure amplification of theerbB-2 gene and of chromosome 20q in breast cancers. This method, termed ‘differentially competitive polymerase chain reaction’ (DC-PCR) combines the advantages of two other techniques for measuring amplification by PCR, namely differential PCR and competitive PCR. The DC-PCR methodology was evaluated for sensitivity and specificity by comparing amplification oferbB-2 measured by DC-PCR with that obtained by fluorescencein situ hybridization (FISH) for 42 cases or Southern blotting and/or slot blot analysis for 34 cases. There was over 90 percent concordance with both FISH and Southern blotting and/or slot blot analysis. DC-PCR was used to further characterize the newly described amplicon at chromosome 20q. By analyzing DNA from 10 breast cancer cell lines at 7 different loci, we identified a potential common region of amplification of approximately 5 centimorgans at chromosome 20q13 bordered by loci D20S52 and RMC20C001-S1. One hundred and seventeen cases of primary breast cancer were evaluated for amplification at these two loci. Amplification at one or more loci, defined as > 1.5 fold higher copy number than that of normal DNA, was found in 25 cases (21%). Sixteen cases were amplified at only one of the two probes (12 cases for RMC20C001-S1 and 4 cases for D20S52), suggesting that the target gene lies between the two markers or that there are two independent target genes within a small chromosome region.Keywords
This publication has 21 references indexed in Scilit:
- c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapseEuropean Journal Of Cancer, 1992
- A Comprehensive Genetic Linkage Map of the Human GenomeScience, 1992
- Competitive PCRNature, 1992
- Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2/neu amplificationThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphismsGenomics, 1992
- c‐myc amplification is an independent prognostic factor in postmenopausal breast cancerInternational Journal of Cancer, 1992
- Generation of competitor DNA fragments for quantitative PCR.Genome Research, 1991
- Amplification of the proto-oncogenes int-2, c-erbB-2 and c-myc in human breast cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Amplification of a Novel v- erb B-Related Gene in a Human Mammary CarcinomaScience, 1985